Cis-platinum as second-line chemotherapy in advanced gastric adenocarcinoma. A phase II study of the EORTC gastrointestinal tract cancer cooperative group
- 1 November 1985
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 21 (11) , 1321-1324
- https://doi.org/10.1016/0277-5379(85)90311-6
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Further studies on the treatment of advanced gastric cancer by 5-fluorouracil, adriamycin (Doxorubicin), and mitomycin C (modified FAM)Cancer, 1984
- CisplatinAnnals of Internal Medicine, 1984
- Cisplatin.An active drug in the treatment of disseminated gastric cancerCancer, 1984
- Randomized study of combination chemotherapy in unresectable gastric cancerCancer, 1984
- A phase II study of cisplatin in advanced gastric cancerEuropean Journal of Cancer and Clinical Oncology, 1983
- Phase II clinical trial of cis-dichlorodiammineplatinum in gastric cancerAmerican Journal of Clinical Oncology, 1983
- PHASE-II CLINICAL-TRIAL OF CIS-DICHLORODIAMMINEPLATINUM IN GASTRIC-CANCER1983
- 5-Fluorouracil, Doxorubicin, and Mitomycin (FAM) Combination Chemotherapy for Advanced Gastric CancerAnnals of Internal Medicine, 1980